Found: 19
Select item for more details and to access through your institution.
Factors that predict changing the type of phosphodiesterase type 5 inhibitor medication among men in the UK.
- Published in:
- BJU International, 2007, v. 99, n. 4, p. 860, doi. 10.1111/j.1464-410X.2006.06668.x
- By:
- Publication type:
- Article
Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20061-6
- By:
- Publication type:
- Article
Machine learning models for identifying predictors of clinical outcomes with first-line immune checkpoint inhibitor therapy in advanced non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-20061-6
- By:
- Publication type:
- Article
The relative burden of community-acquired pneumonia hospitalizations in older adults: a retrospective observational study in the United States.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differences in Healthcare Utilization and Associated Costs Between Patients Prescribed vs. Nonprescribed Opioids During an Inpatient or Emergency Department Visit.
- Published in:
- Pain Practice, 2014, v. 14, n. 5, p. 446, doi. 10.1111/papr.12098
- By:
- Publication type:
- Article
Real-World Evaluation of Health-Care Resource Utilization and Costs in Employees with Fibromyalgia Treated with Pregabalin or Duloxetine.
- Published in:
- Pain Practice, 2011, v. 11, n. 3, p. 217, doi. 10.1111/j.1533-2500.2010.00440.x
- By:
- Publication type:
- Article
Identifying Fibromyalgia-Associated Symptoms and Conditions from a Clinical Perspective: A Step Toward Evaluating Healthcare Resource Utilization in Fibromyalgia silverman et al. FM-Associated Symptoms and Conditions.
- Published in:
- Pain Practice, 2010, v. 10, n. 6, p. 520, doi. 10.1111/j.1533-2500.2010.00383.x
- By:
- Publication type:
- Article
Impaired Quality of Life, Work, and Activities Among Adults with Clostridium difficile Infection: A Multinational Survey.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA Decisions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 325, doi. 10.1002/cpt.2914
- By:
- Publication type:
- Article
Regulatory and HTA Considerations for Development of Real‐World Data Derived External Controls.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 303, doi. 10.1002/cpt.2913
- By:
- Publication type:
- Article
Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2006, v. 15, n. 1, p. 1, doi. 10.1002/pds.1135
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma Treated in US Oncology Practices.
- Published in:
- Cancer Management & Research, 2024, v. 16, p. 841, doi. 10.2147/CMAR.S445910
- By:
- Publication type:
- Article
Real-World Outcomes and Prognostic Factors Among Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression Treated with Immune Checkpoint Inhibitors as First-Line Therapy.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 3191, doi. 10.2147/CMAR.S376510
- By:
- Publication type:
- Article
Impact of Treatment by NCQA-Certified Physicians on Diabetes-Related Outcomes.
- Published in:
- American Health & Drug Benefits, 2011, v. 4, n. 7, p. 429
- By:
- Publication type:
- Article
Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 1, p. 118, doi. 10.1002/cncr.34477
- By:
- Publication type:
- Article
Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Real-World Evidence to Contextualize Clinical Trial Results and Inform Regulatory Decisions: Tofacitinib Modified-Release Once-Daily vs Immediate-Release Twice-Daily for Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 1, p. 226, doi. 10.1007/s12325-020-01501-z
- By:
- Publication type:
- Article
Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes.
- Published in:
- Diabetes Care, 2009, v. 32, n. 6, p. 1037, doi. 10.2337/dc08-1720
- By:
- Publication type:
- Article
Use of electronic health records for early detection of high-cost, low back pain patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article